-
Product Insights
Urinary Incontinence – Drugs In Development, 2023
Global Markets Direct’s, ‘Urinary Incontinence - Drugs In Development, 2023’, provides an overview of the Urinary Incontinence pipeline landscape. The report provides comprehensive information on the therapeutics under development for Urinary Incontinence, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Overactive Bladder – Drugs In Development, 2023
Global Markets Direct’s, ‘Overactive Bladder - Drugs In Development, 2023’, provides an overview of the Overactive Bladder pipeline landscape. The report provides comprehensive information on the therapeutics under development for Overactive Bladder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AFM-13 in Cutaneous T-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AFM-13 in Cutaneous T-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AFM-13 in Cutaneous T-Cell Lymphoma Drug Details: AFM-13 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NEO-201 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NEO-201 in Endometrial Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.NEO-201 in Endometrial Cancer Drug Details:NEO-201 (h16C3) is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – pVAX-hSlo in Urinary Incontinence
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - pVAX-hSlo in Urinary Incontinence report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PVAX-hSlo in Urinary Incontinence Drug Details: pVAX-hSlo (hmaxi-K) gene transfer therapy...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – pVAX-hSlo
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry pVAX-hSlo Drug Details pVAX-hSlo (hmaxi-K) gene transfer therapy is under development for the treatment...
-
Product Insights
Overactive Bladder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Overactive Bladder – Drugs In Development, 2022, provides an overview of the Overactive Bladder (Genito Urinary System And Sex Hormones) pipeline landscape. Overactive bladder is a problem with bladder-storage function that causes a sudden urge to urinate. The urge may be difficult to stop, and overactive bladder may lead to the involuntary loss of urine (incontinence). Symptoms include feel a sudden urge to urinate that's difficult to control, experience urge...
-
Product Insights
Urinary Incontinence Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Urinary incontinence is a loss of control of the bladder. In some cases, it may result in a total loss of the bladder’s contents, or it may just cause minor leakage. Symptoms include stress incontinence, rashes, and other skin disorders. Risk factors include age, gender, overweight, smoking, and other kidney diseases. Treatment includes anticholinergics and topical estrogen. The Urinary Incontinence drugs in development market research report provide comprehensive information on the therapeutics under development for Urinary Incontinence, complete with analysis...
-
Sector Analysis
Overactive Bladder: Global Drug Forecast and Market Analysis to 2030
The overactive bladder (OAB) market sales have been valued at $2.2 billion in 2020 across the eight major markets (8MM) covered in this report- the US, 5EU (France, Germany, Italy, Spain, and the UK), Japan and China. The market is projected to grow at a CAGR of more than 2% during the period 2021-2030. The US accounted for the largest market with global sales in 2020, equating to a market share of more than 45%. This largely reflects the large...
-
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...